Literature DB >> 871033

Louse-borne relapsing fever: II. Combined penicillin and tetracycline therapy in 160 Sudanese patients.

S Y Salih, D Mustafa.   

Abstract

One hundred and sixty patients with louse-borne relapsing fever were treated with a combination therapy of procaine penicillin and tetracycline. Fortified procaine penicillin B.P. was given as 400,000 units in the first day. This was followed the next day by 2 g tetracycline orally in divided doses for seven days. A mild rise in temperature was observed in 22 (13-7%) patients within four hours of administering penicillin. Rigors and hypotension occurred in one patient. Relapse occurred in two patients, of whom one had concomitant typhoid and one visceral leishmaniasis. The combined therapy has been found to be effective and safe. It lacks the disadvantages of penicillin (relapses) and tetracycline (severe reaction), when each drug is used alone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871033     DOI: 10.1016/0035-9203(77)90207-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  Outbreak of Louse-Borne Relapsing Fever among Urban Dwellers in Arsi Zone, Central Ethiopia, from July to November 2016.

Authors:  Tamara Nordmann; Torsten Feldt; Matthias Bosselmann; Tafese Beyene Tufa; Gorfnesh Lemma; Martha Holtfreter; Dieter Häussinger
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

Review 2.  Louse-borne relapsing fever (Borrelia recurrentis infection).

Authors:  David A Warrell
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

3.  Louse-borne relapsing fever-A systematic review and analysis of the literature: Part 2-Mortality, Jarisch-Herxheimer reaction, impact on pregnancy.

Authors:  Pascal Kahlig; Andreas Neumayr; Daniel H Paris
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.